One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China

Abstract

IMPORTANCE Determining the long-term impact of COVID-19 on cognition is important to inform immediate steps in COVID-19 research and health policy.OBJECTIVE To investigate the 1-year trajectory of cognitive changes in older COVID-19 survivors.DESIGN, SETTING, AND PARTICIPANTS This cohort study recruited 3233 COVID-19 survivors 60 years and older who were discharged from 3 COVID-19-designated hospitals in Wuhan, China, from February 10 to April 10, 2020. Their uninfected spouses (N = 466) were recruited as a control population. Participants with preinfection cognitive impairment, a concomitant neurological disorder, or a family history of dementia were excluded, as well as those with severe cardiac, hepatic, or kidney disease or any kind of tumor. Follow-up monitoring cognitive functioning and decline took place at 6 and 12 months. A total of 1438 COVID-19 survivors and 438 control individuals were included in the final follow-up. COVID-19 was categorized as severe or nonsevere following the American Thoracic Society guidelines. MAIN OUTCOMES AND MEASURES The main outcome was change in cognition 1 year after patient discharge. Cognitive changes during the first and second 6-month follow-up periods were assessed using the Informant Questionnaire on Cognitive Decline in the Elderly and the Telephone Interview of Cognitive Status-40, respectively. Based on the cognitive changes observed during the 2 periods, cognitive trajectories were classified into 4 categories: stable cognition, early-onset cognitive decline, late-onset cognitive decline, and progressive cognitive decline. Multinomial and conditional logistical regression models were used to identify factors associated with risk of cognitive decline.RESULTS Among the 3233 COVID-19 survivors and 1317 uninfected spouses screened, 1438 participants who were treated for COVID-19 (691 male [48.05%] and 747 female [51.95%]; median [IQR] age, 69 [66-74] years) and 438 uninfected control individuals (222 male [50.68%] and 216 female [49.32%]; median [IQR] age, 67 [66-74] years) completed the 12-month follow-up. The incidence of cognitive impairment in survivors 12 months after discharge was 12.45%. Individuals with severe cases had lower Telephone Interview of Cognitive Status-40 scores than those with nonsevere cases and control individuals at 12 months (median [IQR]: severe, 22.50 [16.00-28.00]; nonsevere, 30.00 [26.00-33.00]; control , 31.00 [26.00-33.00]). Severe COVID-19 was associated with a higher risk of early-onset cognitive decline (odds ratio [OR], 4.87; 95% CI, 3.30-7.20), late-onset cognitive decline (OR, 7.58; 95% CI, 3.58-16.03), and progressive cognitive decline (OR, 19.00; 95% CI, 9.14-39.51), while nonsevere COVID-19 was associated with a higher risk of early-onset cognitive decline (OR, 1.71; 95% CI, 1.30-2.27) when adjusting for age, sex, education level, body mass index, and comorbidities. CONCLUSIONS AND RELEVANCEIn this cohort study, COVID-19 survival was associated with an increase in risk of longitudinal cognitive decline, highlighting the import...

The Multifaceted Manifestations of Multisystem Inflammatory Syndrome during the SARS-CoV-2 Pandemic

“…Normal cognitive function is required for normal daily activities throughout life. In a 1-year follow-up study of older COVID-19 survivors, four categories of cognitive function were considered: stable cognition, early-onset cognitive decline, late-onset cognitive decline, and progressive cognitive decline [ 85 ]. Previous severe COVID-19 was associated with a higher risk of early-onset cognitive decline, late-onset cognitive decline, and progressive cognitive decline.…”

COVID-19 in the perioperative setting: A review of the literature and the clinical landscape

“…Neurocognitive dysfunction and damage after COVID infection are also common. 31 , 32 , 33 , 34 , 35 , 36 Delirium is a well-recognized complication of COVID and is associated with a poor prognosis and increased mortality. While specific post-COVID perioperative neurocognitive complications are not yet reported, we remain highly concerned about the risk of postoperative delirium and other postoperative neurocognitive disorders.…”

Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study

“…Given the huge number of individuals who have recovered from COVID-19 up to now, the sequelae after recovery from acute COVID-19 are undoubtedly a great health concern and might cause a big medical and socioeconomic burden. Several cohort studies have highlighted that the health effects of COVID-19 could persist up to 1 year after acute infection, 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 most of which had no control groups of individuals who had not contracted COVID-19 and focused only on symptomatic sequelae or respiratory outcomes. Hence, long-term (ie, beyond 1 year) and overall health outcomes of COVID-19 are largely unknown.…”